Stempoint Capital’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.8M | Buy |
1,300,860
+447,388
| +52% | +$7.16M | 6.68% | 2 |
|
|
2025
Q1 | $14.6M | Sell |
853,472
-265,036
| -24% | -$4.53M | 4.65% | 6 |
|
|
2024
Q4 | $27.7M | Buy |
1,118,508
+447,507
| +67% | +$11.1M | 6.92% | 3 |
|
|
2024
Q3 | $19.1M | Sell |
671,001
-340,878
| -34% | -$9.72M | 5.73% | 4 |
|
|
2024
Q2 | $26.7M | Buy |
1,011,879
+384,651
| +61% | +$10.2M | 7.85% | 3 |
|
|
2024
Q1 | $20.3M | Buy |
627,228
+305,213
| +95% | +$9.86M | 5.36% | 5 |
|
|
2023
Q4 | $13.6M | Buy |
+322,015
| New | +$13.6M | 3.62% | 5 |
|